Competition among health care providers: helpful or harmful?
作者信息
Barros Pedro Pita, Brouwer Werner B F, Thomson Sarah, Varkevisser Marco
机构信息
Universidade Nova de Lisboa, Lisbon, Portugal.
Erasmus University Rotterdam, Rotterdam, The Netherlands.
出版信息
Eur J Health Econ. 2016 Apr;17(3):229-33. doi: 10.1007/s10198-015-0736-3.
Abstract
摘要
相似文献
1
Competition among health care providers: helpful or harmful?医疗服务提供者之间的竞争：有益还是有害？
Eur J Health Econ. 2016 Apr;17(3):229-33. doi: 10.1007/s10198-015-0736-3.
2
Applicability of European Union Competition Law to Health Care Providers: The Dividing Line between Economic and Noneconomic Activities.欧盟竞争法对医疗保健提供者的适用：经济活动与非经济活动的分界线。
J Health Polit Policy Law. 2021 Feb 1;46(1):49-70. doi: 10.1215/03616878-8706603.
3
Patient choice, mobility and competition among health care providers.患者选择、就医便利性以及医疗服务提供者之间的竞争。
Dev Health Econ Public Policy. 2014;12:1-26. doi: 10.1007/978-88-470-5480-6_1.
4
Competition rules and health care players: principles and consequences.竞争规则与医疗保健参与者：原则与后果
Int J Health Care Qual Assur. 2012;25(5):379-86. doi: 10.1108/09526861211235883.
5
Competition and market concentration.竞争与市场集中度
Adv Health Econ Health Serv Res. 2008;18:139-56.
6
NCI oncologists excluded from some US insurance networks.美国国立癌症研究所的肿瘤学家被排除在一些美国保险网络之外。
Lancet Oncol. 2017 Aug;18(8):e442. doi: 10.1016/S1470-2045(17)30537-5. Epub 2017 Jul 14.
7
Competition, incentives and the English NHS.竞争、激励与英国国民医疗服务体系
Health Econ. 2012 Jan;21(1):33-40. doi: 10.1002/hec.1804.
8
Incentives and models of governance.激励措施与治理模式。
Health Econ Policy Law. 2015 Jul;10(3):345-50. doi: 10.1017/S1744133114000486.
9
Why healthcare providers merge.医疗服务提供者合并的原因。
Health Econ Policy Law. 2016 Apr;11(2):121-40. doi: 10.1017/S1744133115000304. Epub 2015 Jun 9.
10
Market competition, ownership, payment systems and the performance of health care providers - a panel study among Finnish occupational health services providers.市场竞争、所有制、支付制度与医疗机构绩效——芬兰职业健康服务提供商的面板研究。
Health Econ Policy Law. 2013 Oct;8(4):477-510. doi: 10.1017/S174413311200031X. Epub 2012 Oct 12.
引用本文的文献
1
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review.利用定向文献综述的结果定义可持续全球生物类似药市场的框架。
BioDrugs. 2025 May;39(3):411-425. doi: 10.1007/s40259-025-00710-8. Epub 2025 Feb 26.
2
Examining patient choice and provider competition under the National Health Insurance Fund outpatient cover in Kenya: does it enhance access and quality of care?审视肯尼亚国家健康保险基金门诊保险下的患者选择与医疗服务提供者竞争：这是否能提高医疗服务的可及性和质量？
BMC Health Serv Res. 2024 Dec 18;24(1):1569. doi: 10.1186/s12913-024-12021-9.
3
Waiting times spillovers in a National Health Service hospital network: a little organizational diversity can go a long way.英国国家医疗服务体系医院网络中的候诊时间溢出效应：一点组织多样性就能产生很大影响。
Health Econ Rev. 2024 Oct 11;14(1):87. doi: 10.1186/s13561-024-00555-x.
4
Why do consumers choose private over public health services? Reflective accounts of health providers in Vietnam.消费者为何选择私立而非公立医疗服务？越南医疗服务提供者的反思性叙述。
BMC Health Serv Res. 2023 Aug 23;23(1):900. doi: 10.1186/s12913-023-09892-9.
5
Including mental health care in a model of European health system.将精神卫生保健纳入欧洲卫生系统模式。
Epidemiol Psychiatr Sci. 2023 Feb 20;32:e12. doi: 10.1017/S2045796023000057.
6
Competition and quality of care under regulated fees: evidence from Ghana.管制费用下的竞争与医疗服务质量：来自加纳的证据
Health Econ Rev. 2022 Nov 10;12(1):57. doi: 10.1186/s13561-022-00406-7.
7
The impact of price transparency and competition on hospital costs: a research on all-payer claims databases.价格透明度和竞争对医院成本的影响：基于所有支付者索赔数据库的研究。
BMC Health Serv Res. 2022 Nov 5;22(1):1321. doi: 10.1186/s12913-022-08711-x.
8
Health services in Nordic welfare states: Introducing a new category of providers through the Norwegian free treatment choice reform.北欧福利国家的医疗服务：通过挪威免费治疗选择改革引入新的医疗服务提供者类别。
Nordisk Alkohol Nark. 2022 Oct;39(5):487-502. doi: 10.1177/14550725221108790. Epub 2022 Jul 11.
9
Does competition improve hospital performance: a DEA based evaluation from the Netherlands.竞争是否能提高医院绩效：来自荷兰的基于 DEA 的评估。
Eur J Health Econ. 2023 Aug;24(6):999-1017. doi: 10.1007/s10198-022-01529-8. Epub 2022 Oct 4.
10
The relations between business model efficiency and novelty, and outcome while accounting for managed competition contract: a quantitative study among Dutch physiotherapy primary healthcare organisations.在考虑管理竞争合同的情况下，商业模式效率和新颖性与结果之间的关系：荷兰物理治疗初级保健组织的定量研究。
BMC Health Serv Res. 2022 Aug 3;22(1):990. doi: 10.1186/s12913-022-08383-7.
本文引用的文献
1
Does Hospital Competition Save Lives? Evidence from the English NHS Patient Choice Reforms.医院竞争能挽救生命吗？来自英国国民医疗服务体系患者选择改革的证据。
Econ J (London). 2011 Aug;121(554):F228-F260. doi: 10.1111/j.1468-0297.2011.02449.x.
2
Does hospital competition harm equity? Evidence from the English National Health Service.医院竞争是否会损害公平性？来自英国国家医疗服务体系的证据。
J Health Econ. 2013 Mar;32(2):410-22. doi: 10.1016/j.jhealeco.2012.11.009. Epub 2012 Dec 22.
3
Tendering for outpatient prescription pharmaceuticals: what can be learned from current practices in Europe?招标采购门诊处方药：从欧洲目前的做法中可以学到什么？
Health Policy. 2011 Jul;101(2):146-52. doi: 10.1016/j.healthpol.2011.03.004. Epub 2011 Apr 21.
4
Pharmaceutical policy in the Netherlands: from price regulation towards managed competition.荷兰的药品政策：从价格监管走向管理式竞争。
Adv Health Econ Health Serv Res. 2010;22:53-76. doi: 10.1108/s0731-2199(2010)0000022006.
5
Equity, waiting times, and NHS reforms: retrospective study.公平性、候诊时间与英国国民医疗服务体系改革：回顾性研究
BMJ. 2009 Sep 3;339:b3264. doi: 10.1136/bmj.b3264.
Zotero 插件